Docs, Scientists Call on FDA to Delay Approval of COVID Vaccines

The 27-member petition, which is led by Dr. Linda Wastila, a professor of pharmaceutical health services research at the University of Maryland School of Pharmacy, calls the notion of approval to stimulate vaccination rates “backward logic.” The group of clinicians and researchers claim data should be from completed phase III trials, not interim results. “Slow down and get the science right,” the group wrote in a blog post published in The British Medical Journal.